Doctors Weigh Prescribing Controversial Alzheimer’s Drug

Pros and cons of an expensive new drug with questionable value put doctors in difficult situation

The benefits of Aduhelm for each suitable patient are hard to predict. Jacob Lund/Shutterstock

As physicians and health policy experts debate the merits of Aduhelm, the first new drug approved for Alzheimer’s disease in 18 years, patients want to know: “Will this medication help me—and how much?”

Doctors explaining the pros and cons of Aduhelm won’t have a definitive answer.